4.7 Article

Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin

Journal

SCIENTIFIC REPORTS
Volume 8, Issue -, Pages -

Publisher

NATURE RESEARCH
DOI: 10.1038/s41598-018-19261-w

Keywords

-

Funding

  1. National Cancer Institute [1R01CA206561-01]
  2. Wisconsin Ovarian Cancer Alliance (WOCA)
  3. Department of Obstetrics and Gynecology
  4. National Science Foundation [CBET-1554027]
  5. DOD Breast Cancer Research Program [DOD-BC121998]
  6. Mary Kay Foundation [067-14]
  7. NIH [NCI R01 CA185747, NCI R01 CA205101]
  8. University of Wisconsin Carbone Cancer Center Support Grant [P30 CA014520]

Ask authors/readers for more resources

Plumbagin, an anti-cancer agent, is toxic to cells of multiple species. We investigated if plumbagin targets conserved biochemical processes. Plumbagin induced DNA damage and apoptosis in cells of diverse mutational background with comparable potency. A 3-5 fold increase in intracellular oxygen radicals occurred in response to plumbagin. Neutralization of the reactive oxygen species by N-acetylcysteine blocked apoptosis, indicating a central role for oxidative stress in plumbagin-mediated cell death. Plumbagin docks in the ubiquinone binding sites (Q(0) and Q(i)) of mitochondrial complexes I-III, the major sites for oxygen radicals. Plumbagin decreased oxygen consumption rate, ATP production and optical redox ratio (NAD(P) H/FAD) indicating interference with electron transport downstream of mitochondrial Complex II. Oxidative stress induced by plumbagin triggered an anti-oxidative response via activation of Nrf2. Plumbagin and the Nrf2 inhibitor, brusatol, synergized to inhibit cell proliferation. These data indicate that while inhibition of electron transport is the conserved mechanism responsible for plumbagin's chemotoxicity, activation of Nrf2 is the resulting anti-oxidative response that allows plumbagin to serve as a chemopreventive agent. This study provides the basis for designing potent and selective plumbagin analogs that can be coupled with suitable Nrf2 inhibitors for chemotherapy or administered as single agents to induce Nrf2-mediated chemoprevention.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemical Research Methods

DBSI server: DNA binding site identifier

Shravan Sukumar, Xiaolei Zhu, Spencer S. Ericksen, Julie C. Mitchell

BIOINFORMATICS (2016)

Article Chemistry, Medicinal

Machine Learning Consensus Scoring Improves Performance Across Targets in Structure-Based Virtual Screening

Spencer S. Ericksen, Haozhen Wu, Huikun Zhang, Lauren A. Michael, Michael A. Newton, F. Michael Hoffmann, Scott A. Wildman

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)

Review Oncology

Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer

Amruta P. Nayak, Arvinder Kapur, Lisa Barroilhet, Manish S. Patankar

CANCERS (2018)

Article Chemistry, Medicinal

Practical Model Selection for Prospective Virtual Screening

Shengchao Liu, Moayad Alnammi, Spencer S. Ericksen, Andrew F. Voter, Gene E. Ananiev, James L. Keck, F. Michael Hoffmann, Scott A. Wildman, Anthony Gitter

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)

Article Biochemical Research Methods

Predicting kinase inhibitors using bioactivity matrix derived informer sets

Huikun Zhang, Spencer S. Ericksen, Ching-pei Lee, Gene E. Ananiev, Nathan Wlodarchak, Peng Yu, Julie C. Mitchell, Anthony Gitter, Stephen J. Wright, F. Michael Hoffmann, Scott A. Wildman, Michael A. Newton

PLOS COMPUTATIONAL BIOLOGY (2019)

Article Multidisciplinary Sciences

A marine microbiome antifungal targets urgent-threat drug-resistant fungi

Fan Zhang, Miao Zhao, Doug R. Braun, Spencer S. Ericksen, Jeff S. Piotrowski, Justin Nelson, Jian Peng, Gene E. Ananiev, Shaurya Chanana, Kenneth Barns, Jen Fossen, Hiram Sanchez, Marc G. Chevrette, Ilia A. Guzei, Changgui Zhao, Le Guo, Weiping Tang, Cameron R. Currie, Scott R. Rajski, Anjon Audhya, David R. Andes, Tim S. Bugni

SCIENCE (2020)

Article Biology

Bayes optimal informer sets for early-stage drug discovery

Peng Yu, Spencer Ericksen, Anthony Gitter, Michael A. Newton

Summary: This study addresses an important experimental design problem in early-stage drug discovery, focusing on prioritizing compounds for testing when little is known about the target protein. The Informer-based ranking (IBR) method is introduced as a solution, which selects a set of informer compounds and prioritizes the remaining compounds based on new bioactivity experiments. The Bayes Optimal Informer SEt (BOISE) method is proposed to efficiently solve this two-stage decision problem and outperforms other available methods in predicting protein-kinase inhibition and anticancer drug sensitivity.

BIOMETRICS (2023)

Article Chemistry, Medicinal

In Silico Modeling and Scoring of PROTAC-Mediated TernaryComplex Poses

Junzhuo Liao, Xueqing Nie, Ilona Christy Unarta, Spencer S. Ericksen, Weiping Tang

Summary: This study demonstrates a method to distinguish native and non-native ternary complex poses based on the pose occupancy time. Using a specific heating scheme to accelerate pose departure, the native pose can be identified accurately. The dynamic scoring method takes into account the effect of entropy and is more reliable in determining the native pose.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Oncology

Atovaquone: An Inhibitor of Oxidative Phosphorylation as Studied in Gynecologic Cancers

Arvinder Kapur, Pooja Mehta, Aaron D. Simmons, Spencer S. Ericksen, Geeta Mehta, Sean P. Palecek, Mildred Felder, Zach Stenerson, Amruta Nayak, Jose Maria Ayuso Dominguez, Manish Patankar, Lisa M. Barroilhet

Summary: The Warburg effect, characterized by high glucose uptake and lactate release, is a hallmark of most cancers. Atovaquone, a mitochondrial complex III inhibitor, has been found to slow ovarian cancer growth and inhibit the proliferation of cancer stem cells both in vitro and in vivo. The drug is able to inhibit oxygen consumption and ATP production, and it alters several metabolic pathways. These findings provide mechanistic insights and preclinical data to support further investigation of atovaquone as a potential therapy for gynecologic cancers.

CANCERS (2022)

Article Biology

Multivariate chemogenomic screening prioritizes new macrofilaricidal leads

Nicolas J. Wheeler, Kaetlyn T. Ryan, Kendra J. Gallo, Clair R. Henthorn, Spencer S. Ericksen, John D. Chan, Mostafa Zamanian

Summary: The development of direct acting macrofilaricides for the treatment of human filariases faces limitations in screening throughput due to the parasite life cycle. A multivariate screen using microfilariae identified dozens of compounds with submicromolar macrofilaricidal activity, achieving a hit rate of over 50%. Thorough characterization of compound activity on adult traits led to the discovery of five compounds with high potency against adults, but low potency or slow-acting microfilaricidal effects.

COMMUNICATIONS BIOLOGY (2023)

Article Chemistry, Medicinal

Evaluating Scalable Supervised Learning for Synthesize-on-Demand Chemical Libraries

Moayad Alnammi, Shengchao Liu, Spencer Ericksen, Gene Ananiev, Andrew Voter, Song Guo, James Keck, F. Michael Hoffmann, Scott Wildman, Anthony Gitter

Summary: Traditional small-molecule drug discovery is time-consuming and costly. Modern machine-learning methods for virtual chemical screening show strong predictive power. This study validates the use of ligand-based virtual screening in large commercial libraries and demonstrates the superior performance of a random forest classifier.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2023)

Meeting Abstract Oncology

Targeting tumors by inhibiting mitochondrial electron transport

Arvinder Kapur, Amruta P. Nayak, Thomas Beres, Kavya Rathi, Mildred Felder, Amani Gillette, Spencer Ericksen, Melissa Skala, Lisa Barroilhet, Manish S. Patankar

CANCER RESEARCH (2017)

No Data Available